Tricyclic compounds as inhibitors of mutant idh enzymes

Christian Fischer, Natick, MA (US);

Stephane L. Bogen, Somerset, NJ (US);

Matthew L. Childers, Medfield, MA (US);

Francesc Xavier Fradera Llinas, Brookline, MA (US);

J. Michael Ellis, Needham, MA (US);

Sara Esposite, Houston, PA (US);

Qingmei Hong, Scotch Plains, NJ (US);

Chunhui Huang, Arlington, MA (US);

Alexander J. Kim, Eastvale, CA (US);

John W. Lampe, Norfolk, MA (US);

Michelle R. Machacek, Belmont, MA (US);

Daniel R. Mcmasters, Brookline, MA (US);

Ryan D. Otte, Natick, MA (US);

Dann L. Parker, Jr., Cranford, NJ (US);

Michael Reutershan, Brighton, MA (US);

Nunzio Sciammetta, Sudbury, MA (US);

Pengcheng P. Shao, Fanwood, NJ (US);

David L. Sloman, Brookline, MA (US);

Feroze Ujjainwalla, Ridgewood, NJ (US);

Catherine White, Newton Center, MA (US);

Zhicai Wu, Montvale, NJ (US);

Yang Yu, Edison, NJ (US);

Kake Zhao, Westfield, NJ (US);

Craig Gibeau, Holliston, MA (US);

Tesfaye Biftu, Freehold, NJ (US);

Purakkattle Biju, Westwood, MA (US);

Lei Chen, Basking Ridge, NJ (US);

Joshua Close, Franklin, MA (US);

Peter H. Fuller, Ashland, MA (US);

Xianhai Huang, Warren, NJ (US);

Min K. Park, Morristown, NJ (US);

Valdimir Simov, Boston, MA (US);

David J. Witter, Norfolk, MA (US);

Hongjun Zhang, Boston, MA (US);